Elsiglutide is a pharmaceutical peptide used in the biomedical industry to manage type 2 diabetes and obesity. It acts as a glucagon-like peptide-1 (GLP-1) receptor agonist, helping to regulate blood sugar levels and promote weight loss. Elsiglutide’s mechanism of action includes increasing insulin release, reducing glucagon secretion, and slowing gastric emptying, resulting in improved glycemic control and decreased appetite.
CAT# | R2022 |
CAS | 914009-84-0 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Since the discovery of Substance P (SP) in the early 1930s, its pharmacological actions have been extensively studied. SP has ...
Discovery and Structure Calcitonin, also called thyrocalcitonin, a protein hormone synthesized and secreted in humans and oth ...
Norleual is a potent inhibitor of the HGF/Met system, which inhibited the prosurvival effects of HGF and suppres ...
Dalbavancin, marketed under the brand name of Dalvance, is a new semi-synthetic glycopeptide antibiotic for anti ...
PR 39, a porcine 39-aa peptide antibiotic, was originally isolated from the upper part of the small intestine o ...